5 hours ago
1
angelp
Castle Biosciences (NASDAQ:CSTL) has partnered with SciBase Holding AB to develop a diagnostic test aimed at forecasting flare-ups in individuals suffering from atopic dermatitis.
The agreement will leverage SciBase's electrical impedance spectroscopy technology, which encompasses both desktop and portable diagnostic devices.
English (US) ·